The Genbody COVID-19 Rapid Antigen Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasal pharyngeal swab specimens.
Expiration Date: 05/31/2024
CLIA Waived
Time to results in 15-20 mins
Collection Method:Anterior Nasal
For use in the Point-of-Care setting
For use under an Emergency Use Authorization (EUA) Only
For in vitro diagnostic use only
Identifies acute infection with a 92.31% sensitivity and 99.04 specificity
